Scotiabank analyst George Farmer initiates coverage on Tempest Therapeutics (NASDAQ:TPST) with a Sector Outperform rating and announces Price Target of $13.
Scotiabank Initiates Coverage On Tempest Therapeutics With Sector Outperform Rating, Announces Price Target of $13
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.